Clinical trial
Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy for Vitreous Hemorrhaging
NCT03660371 is registered in ClinicalTrials.gov with Rush Eye Associates as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Internal Limiting Membrane Peeling in Proliferative Diabetic Retinopathy Patients Undergoing Vitrectomy for Vitreous Hemorrhaging
- Lead sponsor
- Rush Eye Associates
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- September 4, 2018
- Completion date
- March 4, 2020
- Enrollment
- 258 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.